NRXN1 as a novel potential target for small cell lung cancer
Research by Yotsumoto, et al. reported that the authors identified transmembrane proteins overexpressed specifically in…
Browsing: SCLC
RethiNKing which immune cells are the best weapon against lung cancer
Immune cells called ‘natural killer’ (NK) cells could be a powerful weapon for fighting lung…
Intratumoral heterogeneity may be responsible for chemotherapy resistance in patients with small cell lung cancer
Small cell lung cancer (SCLC) accounts for 14% of all lung cancers and is often…
AACR 2019: Two KEYNOTE trials show pembrolizumab benefit for advanced SCLC
The anti-PD-1 monoclonal antibody pembrolizumab (Keytruda) showed promising antitumour activity with durable responses in patients…
Prophylactic cranial irradiation: Improvements for advanced NSCLC
Prophylactic cranial irradiation (PCI), a technique used to prevent the clinical development of brain metastases,…
Aggressive lung cancer’s aggressiveness may be its Achilles’ heel
Researchers at the University of Virginia School of Medicine have discovered a flaw in the…
Newly discovered clues to the cause of chemoresistance in small cell lung cancer
Small cell lung cancer is not usually detected until it is at an advanced stage,…
Study shows statins could be effective against small cell lung cancer
In a recent study, researchers at Cancer Treatment Centers of America (CTCA) at Western Regional…